Nevirapine should not be prescribed for needlestick injuriesBMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7279.126/a (Published 20 January 2001) Cite this as: BMJ 2001;322:126
- Scott Gottlieb
- New York
US federal health officials have advised doctors not to prescribe nevirapine, a standard AIDS prevention drug, to healthy healthcare workers injured by needles.
The drug, marketed under the brand name Viramune, can produce liver damage severe enough to necessitate liver transplantation, the Centers for Disease Control and Prevention (CDC) said in its weekly report.
The US Food and Drug Administration (FDA) has identified 22 cases over the past three years of severe liver, skin, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial